Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04. Recall
Ongoing
Drugs
Class II — Moderate
Recall Date
Mar 11, 2026
Company
New Life Pharma LLC
Source
FDA
Units
45 vials
Reason: Lack of Assurance of Sterility
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Recall Details
Description
Lack of Assurance of Sterility
Reason for Recall
Lack of Assurance of Sterility
What Should I Do?
Quantity: 45 vials
Remediation GuideAction Required
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
1
Confirm Your Product Is Affected2
Read the Full Recall Notice3
Stop Using the Product if in Doubt+2 more steps…
Last updated March 25, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.